| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| MNKD MannKind Corp | 4,024,362,464.78 | 11,335,799,373.38 | 15,625,868,575.56 |
| ADPT Adaptive Biotechnologies Corp | 1,738,545,308.08 | 8,890,640,309.24 | 15,498,559,319.61 |
| CGEM Cullinan Therapeutics Inc | 3,264,392,546.61 | 10,811,335,783.51 | 15,293,727,256.21 |
| CELC Celcuity Inc | 2,345,649,347.95 | 15,021,133,814.64 | 15,037,150,140.38 |
| GLUE Monte Rosa Therapeutics Inc | 6,581,635,809.15 | 12,693,554,167.53 | 14,526,554,730.01 |
| VCEL Vericel Corp | 3,171,769,534.59 | 7,012,023,229.24 | 14,319,100,664.56 |
| ALLO Allogene Therapeutics Inc | 1,194,590,449.99 | 8,236,213,871.0 | 13,892,535,681.19 |
| SANA Sana Biotechnology Inc | 3,265,087,535.1 | 5,110,029,263.53 | 13,755,464,995.94 |
| ORIC Oric Pharmaceuticals Inc | 1,569,031,296.32 | 9,337,928,585.89 | 13,621,521,758.92 |
| NKTX Nkarta Inc | 1,899,024,469.41 | 9,138,308,936.18 | 13,496,550,191.55 |
| COGT Cogent Biosciences Inc | 3,958,180,605.92 | 12,549,091,331.94 | 13,455,387,918.47 |
| ERAS Erasca Inc | 2,218,592,815.1 | 9,474,746,548.04 | 13,280,629,902.62 |
| TRDA Entrada Therapeutics Inc | 2,946,940,756.79 | 10,685,669,227.65 | 13,043,607,235.79 |
| SRRK Scholar Rock Holding Corp | 9,059,175,019.03 | 12,342,711,339.61 | 13,006,330,580.2 |
| BHVN Biohaven Ltd | 5,839,388,097.58 | 10,223,122,794.52 | 12,924,353,528.3 |
| PHVS Pharvaris NV | 12,207,884,508.6 | 12,500,815,711.79 | 12,564,185,294.1 |
| ZYME Zymeworks Inc | 2,048,131,091.76 | 9,215,294,707.09 | 12,549,881,091.59 |
| PRAX Praxis Precision Medicines Inc | 4,723,615,660.88 | 8,650,837,688.43 | 12,522,049,961.44 |
| KMDA Kamada Ltd | 2,274,413,027.32 | 6,088,541,472.67 | 11,916,209,537.01 |
| ARQT Arcutis Biotherapeutics Inc | 1,488,538,992.56 | 11,032,120,991.89 | 11,719,306,660.51 |
| RCKT Rocket Pharmaceuticals Inc | 2,399,226,642.76 | 7,192,499,104.97 | 11,626,304,563.86 |
| STOK Stoke Therapeutics Inc | 2,634,448,657.59 | 8,606,390,015.2 | 11,380,878,854.33 |
| ANAB AnaptysBio Inc | 3,469,666,875.42 | 10,445,361,160.66 | 11,154,502,147.61 |
| PRTA Prothena Corporation PLC | 10,451,458,105.17 | 10,739,909,920.56 | 11,139,654,666.14 |
| OLMA Olema Pharmaceuticals Inc | 1,113,877,013.53 | 10,561,582,191.08 | 11,134,126,348.58 |
| FATE Fate Therapeutics Inc | 1,283,264,663.75 | 6,989,404,512.8 | 10,856,699,577.94 |
| CLLS Cellectis SA | 6,072,398,785.38 | 6,987,572,270.41 | 10,836,923,996.24 |
| AVIR Atea Pharmaceuticals Inc | 2,443,326,821.74 | 10,618,729,199.52 | 10,834,333,584.58 |
| ALEC Alector Inc | 2,416,759,307.04 | 9,489,278,125.64 | 10,591,782,600.19 |
| REPL Replimune Group Inc | 3,884,069,560.15 | 8,856,491,101.88 | 10,538,236,895.76 |
| ZNTL Zentalis Pharmaceuticals Inc | 1,234,299,565.31 | 9,107,571,490.52 | 10,337,953,847.95 |
| MDXG MiMedx Group Inc | 4,488,456,826.83 | 8,026,959,153.54 | 10,076,954,078.08 |
| SEER Seer Inc | 1,420,714,433.63 | 6,771,809,933.41 | 9,749,045,870.46 |
| GHRS GH Research PLC | 7,886,666,248.91 | 9,312,529,915.47 | 9,540,991,587.67 |
| TYRA Tyra Biosciences Inc | 1,957,056,008.66 | 8,883,722,014.69 | 9,535,589,631.65 |
| TERN Terns Pharmaceuticals Inc | 4,760,608,002.99 | 9,486,434,990.9 | 9,529,271,554.43 |
| IMNM Immunome Inc | 8,612,771,273.19 | 8,842,907,235.86 | 9,457,435,016.47 |
| ADCT ADC Therapeutics SA | 7,415,464,049.99 | 9,071,147,775.36 | 9,153,567,092.67 |
| VYGR Voyager Therapeutics Inc | 1,425,516,172.31 | 6,936,774,929.57 | 9,107,855,803.99 |
| ARCT Arcturus Therapeutics Holdings Inc | 5,697,642,035.19 | 7,872,324,213.63 | 8,919,324,379.81 |
| PLRX Pliant Therapeutics Inc | 2,961,030,068.99 | 7,758,219,739.07 | 8,737,900,792.49 |
| LQDA Liquidia Corp | 4,975,359,447.63 | 7,162,140,743.94 | 8,718,346,343.5 |
| SLDB Solid Biosciences Inc | 1,938,512,452.03 | 7,734,969,214.91 | 8,653,049,015.46 |
| MGNX MacroGenics Inc | 2,531,306,047.01 | 7,331,844,298.01 | 8,553,507,708.89 |
| CCCC C4 Therapeutics Inc | 1,857,799,015.57 | 6,534,913,628.12 | 8,386,868,422.26 |
| XOMA Xoma Royalty Corp | 1,427,537,957.02 | 3,497,276,872.87 | 8,313,041,689.97 |
| TCRX TScan Therapeutics Inc | 5,354,759,984.57 | 5,944,204,998.62 | 8,283,788,992.45 |
| EYPT EyePoint Inc | 2,355,916,223.43 | 6,826,871,976.37 | 7,951,142,226.92 |
| ABSI Absci Corp | 299,350,498.59 | 5,528,128,023.43 | 7,739,391,868.96 |
| WVE WAVE Life Sciences Ltd | 6,198,602,377.81 | 6,807,349,117.76 | 7,625,224,213.63 |
| IMRX Immuneering Corp | 7,188,805,557.03 | 7,237,415,263.63 | 7,615,060,638.72 |
| PHAT Phathom Pharmaceuticals Inc | 4,269,630,222.38 | 6,563,945,192.94 | 7,590,822,283.18 |
| AGEN Agenus Inc | 109,239,555.1 | 4,231,532,216.76 | 7,388,706,992.98 |
| CMPX Compass Therapeutics Inc. | 1,459,854,921.99 | 6,985,266,172.22 | 7,305,561,096.79 |
| ABEO Abeona Therapeutics Inc | 2,618,337,560.68 | 6,827,630,145.63 | 7,300,380,273.47 |
| ANNX Annexon Inc | 4,404,300,038.28 | 6,091,321,426.65 | 7,238,684,249.43 |
| KOD Kodiak Sciences Inc | 2,275,708,233.15 | 2,392,276,757.82 | 6,888,883,904.26 |
| ACIU AC Immune SA | 1,100,869,488.84 | 4,513,878,406.59 | 6,810,025,246.77 |
| FULC Fulcrum Therapeutics Inc | 1,487,212,196.35 | 6,503,291,651.65 | 6,787,447,174.53 |
| MXCT MaxCyte Inc | 409,822,078.75 | 3,937,583,674.19 | 6,743,789,260.95 |
| DSGN Design Therapeutics Inc | 476,635,745.33 | 6,603,306,814.01 | 6,689,896,062.28 |
| TIL Instil Bio Inc | 183,255,829.71 | 6,200,055,535.57 | 6,689,832,881.51 |
| VTYX Ventyx Biosciences Inc | 1,009,944,643.3 | 6,352,637,100.38 | 6,680,260,994.52 |
| TNGX Tango Therapeutics Inc | 1,842,919,943.72 | 5,173,841,843.43 | 6,638,277,371.41 |
| STRO Sutro Biopharma Inc | 2,082,659,383.76 | 5,753,019,982.01 | 6,623,177,166.86 |
| GOSS Gossamer Bio Inc | 282,196,918.94 | 6,444,091,268.11 | 6,596,704,423.31 |
| LXRX Lexicon Pharmaceuticals Inc | 1,568,652,211.69 | 3,870,675,236.45 | 6,505,313,436.36 |
| PBYI Puma Biotechnology Inc | 1,690,875,415.47 | 4,535,747,634.8 | 6,408,488,902.99 |
| EDIT Editas Medicine Inc | 5,232,884,275.04 | 5,588,054,985.85 | 6,373,391,984.04 |
| NAUT Nautilus Biotechnology Inc | 754,220,467.9 | 4,243,378,611.54 | 6,346,982,421.27 |
| TRVI Trevi Therapeutics Inc | 1,796,513,666.55 | 6,264,341,971.26 | 6,297,733,009.36 |
| CRBU Caribou Biosciences Inc | 352,043,262.59 | 4,912,494,579.31 | 6,159,619,841.37 |
| AURA Aura Biosciences Inc | 1,502,217,629.74 | 5,374,156,481.63 | 6,002,931,526.37 |
| CABA Cabaletta Bio Inc | 1,901,930,784.93 | 5,198,545,525.36 | 5,994,560,074.05 |
| MGTX MeiraGTx Holdings PLC | 468,832,919.96 | 1,079,569,854.24 | 5,985,462,042.86 |
| ANIK Anika Therapeutics Inc | 1,831,926,489.36 | 3,209,267,322.88 | 5,984,387,969.73 |
| URGN Urogen Pharma Ltd | 2,844,366,773.16 | 5,324,433,213.93 | 5,845,674,584.41 |
| SABS SAB Biotherapeutics Inc | 929,537,949.49 | 3,578,456,267.52 | 5,795,204,835.88 |
| FBIO Fortress Biotech Inc | 2,723,659,907.91 | 3,743,555,522.82 | 5,730,717,169.43 |
| INBX Inhibrx Biosciences Inc | 4,836,109,025.75 | 5,099,414,893.81 | 5,606,377,409.78 |
| VSTM Verastem Inc | 4,350,185,706.91 | 4,866,688,519.48 | 5,586,822,960.79 |
| VOR Vor Biopharma Inc | 5,069,056,532.77 | 5,448,899,335.12 | 5,567,394,873.34 |
| XBIT XBiotech Inc | 4,655,380,426.93 | 4,705,419,598.49 | 5,446,940,731.18 |
| PGEN Precigen Inc | 452,437,509.58 | 4,094,019,266.11 | 5,410,295,883.32 |
| RAPT RAPT Therapeutics Inc | 1,198,223,344.39 | 5,087,473,727.86 | 5,235,759,000.17 |
| XFOR X4 Pharmaceuticals Inc | 2,199,701,764.22 | 4,195,361,224.68 | 5,166,765,596.95 |
| RZLT Rezolute Inc | 287,409,332.65 | 4,887,285,451.21 | 5,012,257,018.58 |
| CTMX CytomX Therapeutics Inc | 1,079,917,348.49 | 4,713,822,641.19 | 4,999,304,960.29 |
| PRQR ProQR Therapeutics NV | 3,962,563,808.0 | 4,127,468,271.93 | 4,610,095,590.14 |
| MNPR Monopar Therapeutics Inc | 4,033,377,097.35 | 4,551,878,001.84 | 4,555,247,748.33 |
| MCRB Seres Therapeutics Inc | 1,504,902,812.56 | 1,627,757,824.06 | 4,532,367,463.49 |
| ABOS Acumen Pharmaceuticals Inc | 1,479,440,961.37 | 4,174,764,292.95 | 4,492,816,300.11 |
| MOLN Molecular Partners AG | 3,268,321,626.15 | 4,323,951,533.96 | 4,450,542,993.15 |
| ACET Adicet Bio Inc | 919,248,644.83 | 3,364,186,576.27 | 4,437,785,847.54 |
| CBIO Crescent Biopharma Inc | 4,209,892,802.28 | 4,250,897,123.43 | 4,367,971,094.28 |
| XLO Xilio Therapeutics Inc | 3,277,944,822.24 | 3,920,019,419.52 | 4,223,445,077.92 |
| ELDN Eledon Pharmaceuticals Inc | 115,905,126.56 | 3,042,185,770.85 | 4,102,232,766.49 |
| CAPR Capricor Therapeutics Inc | 616,340,436.96 | 3,189,102,547.63 | 3,994,231,870.43 |
| AYTU Aytu Biopharma Inc | 1,030,794,298.12 | 2,562,264,625.37 | 3,948,419,176.62 |
| CDXS Codexis Inc | 800,847,877.77 | 2,406,934,696.97 | 3,915,975,850.1 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例